newsfilter
← Latest News
GlobeNewswire·

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates

Mike Heffernan appointed as Chairman of the Board Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026 Cash on hand of approximately $125 million as of March